Apta Logo

In April 2014, Apta Biosciences successfully raised £1,850,000 for its synthetic molecule business to continue undergoing validation work with partners for therapeutics.

The Story

Apta produces Adaptamers; molecules that have much in common with antibodies, but offer a better performance because of their ease to make and use. Most of us probably don’t think about antibodies too often, but we have a lot to thank them for: our own natural antibodies help us to fight viruses and dangerous bacteria every single day. This is clearly reflected by the market for antibodies and their alternatives, which is deemed to be worth an impressive $60 billion p.a.

Apta Biosciences is headed up by a team of experienced life sciences entrepreneurs. The company was spun-out from Fujitsu in August 2013, where the technology was worked on for more than 10 years.

The round was lead by Ranworth Capital: a UK family office with a life sciences focus.

D

Where are they now?

Apta Biosciences has sinced raised a further round on SyndicateRoom at an uplift on its previous valuation. More details to follow.

See current opportunities

Highview Power Storage

EIS
Property
Highview balances energy production and requirements by storing excess, off-peak energy and selling it to electricity networks at times of peak demand.

Active

Trading status

£15,672

Average investment

£767,950

Total raised

Invrep

SEIS
Financial Services
Invrep, the company determined to make reporting to investors as straightforward as possible, has successfully closed its SEIS funding round with help from angels and sophisticated investors on SyndicateRoom.

Active

Trading status

£8,824

Average investment

£150,000

Total raised

Bactest

EIS
Pharmaceuticals & Biotechnology
Bactest’s technology turns microbial activity into data, offering multiple industry applications. They raised £838,380.

Dissolved

Trading status

£13,478

Average investment

£930,000

Total raised

Pulsar

EIS
Technology, Hardware & Equipment
“Making the world a brighter place, one LED at a time”, Pulsar specialises in providing long-lasting lighting where light failure would be highly visible, or light replacement is complex, dangerous or costly to remedy (e.g. high rise buildings, bridges, etc.)

Insolvency Proceedings

Trading status

£22,076

Average investment

£618,120

Total raised

Bird

EIS
Travel & Leisure
Bird Design produces synthetic shuttlecocks which perform like expensive goose feather shuttles, but are as durable as standard plastic shuttles.

Active

Trading status

£4,456

Average investment

£133,695

Total raised

Canary

EIS
Technology, Hardware & Equipment
Canary is led by none other than Christopher Curry, co-founder of Acorn computers, William Cotton, former MD of Boots International, and Stuart Sheehy, previously at BUPA.

Dissolved

Trading status

£10,458

Average investment

£251,000

Total raised